Stent restenosis    Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients Circulation (2004);109:867-73 N. E. West, et al. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis Catheter Cardiovasc Interv (2004);63:259-64 G. S. Werner, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis Circulation (2004);109:340-4 R. Waksman, et al. Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study J Am Coll Cardiol (2004);44:1386-92 R. Waksman, et al. Inflammation and restenosis after percutaneous coronary interventions Eur Heart J (2004);25:1679-87 K. Toutouzas, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings Am J Cardiol (2004);94:115-8 K. Tanabe, et al. Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) trial Am Heart J (2004);147:E9 H. Tamai, et al. High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention Circulation (2004);109:481-6 N. Takamori, et al. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing Am J Cardiol (2004);93:953-8 G. Stankovic, et al. Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER) Am Heart J (2004);147:16-22 S. K. Sharma, et al. Usefulness of insulin resistance measured by homeostasis model assessment in predicting restenosis after coronary stent placement in nondiabetic patients Am J Cardiol (2004);93:920-2 M. Sekiguchi, et al. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement Am Heart J (2004);147:317-22 H. Schuhlen, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation (2004);110:810-4 B. Scheller, et al. Mechanism of coronary artery restenosis after stenting for acute myocardial infarction Am J Cardiol (2004);94:1037-40 A. Schaefer, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry Heart (2004);90:1183-8 F. Saia, et al. Soft plaque detected on intravascular ultrasound is the strongest predictor of in-stent restenosis: an intravascular ultrasound study Eur Heart J (2004);25:2026-33 M. Sahara, et al. Impact of strut thickness on late luminal loss after coronary artery stent placement Am J Cardiol (2004);93:477-80 S. Z. Rittersma, et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients Am J Cardiol (2004);93:1271-5 E. Regar, et al. Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy Eur Heart J (2004);25:920-5 P. W. Radke, et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries Circulation (2004);110:3773-80 J. J. Popma, et al. Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation Heart (2004);90:1189-93 F. Niroomand, et al. Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial) Catheter Cardiovasc Interv (2004);61:190-5 J. Mehilli, et al. Effects of stent length and lesion length on coronary restenosis Am J Cardiol (2004);93:1340-6, A5 L. Mauri, et al. Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis Eur Heart J (2004);25:2040-7 R. Lopez-Palop, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes Circulation (2004);109:2500-2 P. A. Lemos, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation (2004);109:1366-70 P. A. Lemos, et al. Folate therapy and in-stent restenosis after coronary stenting N Engl J Med (2004);350:2673-81 H. Lange, et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions J Am Coll Cardiol (2004);44:733-9 N. Kipshidze, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial Jama (2005);293:165-71 A. Kastrati, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical Lancet (2004);363:751-6 H. J. Kang, et al. Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials) Am J Cardiol (2004);94:199-201 G. L. Kaluza, et al. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis Catheter Cardiovasc Interv (2005);64:28-34 E. Iofina, et al. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation J Am Coll Cardiol (2004);44:1408-14 T. Inoue, et al. Is overdilatation of 3.0 mm sirolimus-eluting stent associated with a higher restenosis rate? Catheter Cardiovasc Interv (2005);64:129-33 I. Iakovou, et al. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure Am J Cardiol (2004);94:351-4 I. Iakovou, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions J Am Coll Cardiol (2004);43:1954-8 A. Hoye, et al. Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries Am J Cardiol (2004);94:1050-4 Y. J. Hong, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation (2004);109:634-40 D. R. Holmes, Jr., et al. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial Circulation (2004);110:790-5 J. Hausleiter, et al. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting Am Heart J (2004);147:1071-7 A. H. Gomma, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation (2004);109:487-93 A. Gershlick, et al. Circulating monocytes and in-stent neointima after coronary stent implantation J Am Coll Cardiol (2004);43:18-23 D. Fukuda, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis Circulation (2004);109:1085-8 K. Fujii, et al. Contribution of early lumen loss after balloon angioplasty for in-stent restenosis to lumen loss at follow-up Catheter Cardiovasc Interv (2004);63:52-6 K. Fujii, et al. Analysis of nonintervention strategy for in-stent restenosis in Pauci- or asymptomatic patients Am J Cardiol (2004);93:1038-40 H. Eltchaninoff, et al. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions Eur Heart J (2004);25:32-8 M. Degertekin, et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials Circulation (2004);110:1226-30 D. E. Cutlip, et al. Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial Circulation (2004);109:861-6 A. J. Chaves, et al. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Even J Am Coll Cardiol (2004);43:2160-5 H. P. Bestehorn, et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial J Am Coll Cardiol (2004);44:1786-91 P. J. Best, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial Jama (2004);292:2727-34 D. Ardissino, et al. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial Eur Heart J (2004);25:1829-35 F. Alfonso, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT) J Am Coll Cardiol (2004);43:943-9 R. Albiero, et al. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis Am J Cardiol (2004);94:1297-300 F. Airoldi, et al.